Study on TMS Effects in Opioid Use Disorder Decision-Making Capacity
A clinical trial is evaluating the impact of transcranial magnetic stimulation (TMS) on decision-making in individuals with and without opioid use disorder.
Phase III
Neurology / Substance Use Disorder
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
Positive results may lead to increased interest in TMS for substance use disorders, influencing portfolio strategies for companies involved in addiction treatments.
Why it matters
This clinical trial explores the potential of TMS as a therapeutic option for opioid use disorder, which could reshape treatment strategies in addiction medicine. Positive outcomes may lead to increased adoption of TMS, influencing the competitive landscape for companies involved in substance use disorder therapies.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results and any subsequent publications that may validate TMS as a treatment for opioid use disorder.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.